CN109965273A - A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN109965273A CN109965273A CN201910267975.3A CN201910267975A CN109965273A CN 109965273 A CN109965273 A CN 109965273A CN 201910267975 A CN201910267975 A CN 201910267975A CN 109965273 A CN109965273 A CN 109965273A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- children
- vitamin
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title claims abstract description 62
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title claims abstract description 61
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 45
- 230000035764 nutrition Effects 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000009472 formulation Methods 0.000 title abstract description 14
- 235000015097 nutrients Nutrition 0.000 claims abstract description 34
- 229940088594 vitamin Drugs 0.000 claims abstract description 32
- 229930003231 vitamin Natural products 0.000 claims abstract description 32
- 235000013343 vitamin Nutrition 0.000 claims abstract description 32
- 239000011782 vitamin Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 230000035622 drinking Effects 0.000 claims abstract description 19
- 235000008216 herbs Nutrition 0.000 claims abstract description 19
- 230000010354 integration Effects 0.000 claims abstract description 19
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 208000013403 hyperactivity Diseases 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 114
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 25
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 22
- 235000019197 fats Nutrition 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 239000003094 microcapsule Substances 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 235000018102 proteins Nutrition 0.000 claims description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 15
- 229910052791 calcium Inorganic materials 0.000 claims description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 229960005069 calcium Drugs 0.000 claims description 14
- 240000001008 Dimocarpus longan Species 0.000 claims description 13
- 241000196324 Embryophyta Species 0.000 claims description 13
- 235000000235 Euphoria longan Nutrition 0.000 claims description 13
- 241000237502 Ostreidae Species 0.000 claims description 13
- 235000021323 fish oil Nutrition 0.000 claims description 13
- 235000020636 oyster Nutrition 0.000 claims description 13
- 239000005862 Whey Substances 0.000 claims description 12
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 12
- 229910052725 zinc Inorganic materials 0.000 claims description 12
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 229920002774 Maltodextrin Polymers 0.000 claims description 11
- 239000005913 Maltodextrin Substances 0.000 claims description 11
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 11
- 229940035034 maltodextrin Drugs 0.000 claims description 11
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 10
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 10
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 10
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 10
- 244000197580 Poria cocos Species 0.000 claims description 10
- 235000008599 Poria cocos Nutrition 0.000 claims description 10
- -1 lard Substances 0.000 claims description 10
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 235000004347 Perilla Nutrition 0.000 claims description 9
- 244000124853 Perilla frutescens Species 0.000 claims description 9
- 108010073771 Soybean Proteins Proteins 0.000 claims description 9
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 229960003284 iron Drugs 0.000 claims description 9
- 235000019710 soybean protein Nutrition 0.000 claims description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 8
- 235000021277 colostrum Nutrition 0.000 claims description 8
- 210000003022 colostrum Anatomy 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 235000005911 diet Nutrition 0.000 claims description 7
- 230000037213 diet Effects 0.000 claims description 7
- 239000001755 magnesium gluconate Substances 0.000 claims description 7
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 7
- 229960003035 magnesium gluconate Drugs 0.000 claims description 7
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 7
- 239000011691 vitamin B1 Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 239000011647 vitamin D3 Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 229940100688 oral solution Drugs 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 4
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 229920002752 Konjac Polymers 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 244000088415 Raphanus sativus Species 0.000 claims description 3
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 3
- 235000004879 dioscorea Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229940091250 magnesium supplement Drugs 0.000 claims description 3
- 230000036961 partial effect Effects 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 241001300674 Plukenetia volubilis Species 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- 235000019498 Walnut oil Nutrition 0.000 claims description 2
- 241001251949 Xanthium sibiricum Species 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 239000008170 walnut oil Substances 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 101710089165 Protein white Proteins 0.000 claims 1
- 241001247821 Ziziphus Species 0.000 claims 1
- 235000014121 butter Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 11
- 230000036651 mood Effects 0.000 abstract description 6
- 239000013589 supplement Substances 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 2
- 235000013350 formula milk Nutrition 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 201000010099 disease Diseases 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- 240000008866 Ziziphus nummularia Species 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 235000010489 acacia gum Nutrition 0.000 description 6
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 239000011716 vitamin B2 Substances 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000206575 Chondrus crispus Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 230000003925 brain function Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000117 Abnormal behaviour Diseases 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 240000002547 Rosa roxburghii Species 0.000 description 2
- 235000000640 Rosa roxburghii Nutrition 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000004222 ferrous gluconate Substances 0.000 description 2
- 235000013924 ferrous gluconate Nutrition 0.000 description 2
- 229960001645 ferrous gluconate Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000003132 food thickener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- JUMYIBMBTDDLNG-OJERSXHUSA-N hydron;methyl (2r)-2-phenyl-2-[(2r)-piperidin-2-yl]acetate;chloride Chemical compound Cl.C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 JUMYIBMBTDDLNG-OJERSXHUSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 229940099204 ritalin Drugs 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 210000002182 synaptic membrane Anatomy 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 241001218889 Castilia perilla Species 0.000 description 1
- 206010008092 Cerebral artery thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000027691 Conduct disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 239000003194 amino acid receptor blocking agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 235000020243 first infant milk formula Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 239000004090 neuroprotective agent Substances 0.000 description 1
- 230000003557 neuropsychological effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of children's hyperkinetic syndrome tailored version clinical nutrition formulas comprising: 10-25 parts of protein, 3-15 parts of fat, 30-60 parts of carbohydrate, 5-25 parts of dietary fibers, 2-5 parts of macroelements, 0.1-0.4 parts of microelements, 0.000001-0.00001 parts of liposoluble vitamins, 0.05-0.3 parts of water soluble vitamins, 0.01-3 parts of integration of drinking and medicinal herbs ingredients, 0.5-3 parts of natural plants compounds and 0.01-3 parts of new resource foods;The invention further relates to the preparation methods of above-mentioned clinical nutrition formula.Pass through the screening and proportion of said components, the present invention is by selecting reasonable basal nutrient element, using the proportion of general equilibrium, the supplement daily required necessary nutritional ingredient of children's hyperkinetic syndrome patient comprehensively, and the nutrient formulation is easier to be absorbed by children's hyperkinetic syndrome people digest, to improve the memory of patient, concentration and study idea, and stablize patient mood, and alleviate and treat the symptom of related hyperactivity, to improve the psychological problems of patient, patient is made to be easier to incorporate the daily life of normal population.
Description
Technical field
The present invention relates to special medicine purposes formula food fields, and in particular to a kind of children's hyperkinetic syndrome tailored version clinic battalion
Support formula and preparation method thereof.
Background technique
Children's hyperkinetic syndrome is also known as attention deficit hyperactivity disorder (ADHD) or minimal brain dysfunciton syndrome, is a kind of normal
The child behavior abnormal diseases seen, be mainly shown as it is apparent pay attention to disorientation and persistence of attention is of short duration, hyperactivity hyperkinesia,
Mood is inflammable, behavior is got excited with difficulty of learning and conduct disorder.It is biology-psychology-society that most scholars, which accept ADHD,
The disease type that factor cooperatively forms.Biological factor includes biochemistry, science of heredity, immunology, nervous system development barrier
Hinder, Electroencephalo, iconography etc..
Inherent cause plays an important role in hyperactivity morbidity.Congenital constitution defect and organs abnormality, chromosome are different
Often, the inherent causes such as mental disease of parent can influence the brain function of child to some extent, cause its congenital constitution defect, thus
Cause to move more.Mother, which has abnormal pregnancy history, premature labor or postmature delivery and baby to be in a bad state of health in young period, causes ADHD illness rate to increase
Height, may be related with children's impaired brain development caused by unfavorable factor.Family factors include home environment, home education, father
Female schooling, relationship between parents and emotion.Home environment is the principal element for influencing Children's psychological development, good home environment
It is avoided that the generation of children ADHD or mitigates hyperactivity shape, bad domestic environment is to inspire the basis of hyperactivity.
According to incompletely statistics, domestic ADHD disease incidence is increased, it is now recognized that disease incidence is about 3%~5%, Nan Haifa
Sick rate is about 3 times of girl, wherein the symptom of about 50%~60% infant can continue to it is adult in addition it is lifelong in spite of illness, but 80%
ADHD patient do not obtain formal diagnosis.
The main clinical manifestation of ADHD are as follows: (1) attention deficit disorder: children's attention with this disease is obviously compared under child of the same age
Drop, not interested to the things around at one's side, upper class hour likes gazing around, be unable to the attention of oneself in complete set specially cause in
Attention will not be absorbed in thing by something by strong impulse.For disease in school age children, on classroom
Performance just seem more prominent, be embodied in do not pay attention to paying attention to the class, be absent-minded, the symptoms such as thought is sneaked away;(2) activity
Degree: the children with ADHD most it is outstanding performance be exactly it is active, after illness children's activity than previously obviously increases.With the age
Increase, more dynamic, active habits of infant persistently exist.On often just sat down after class or just stand shortly can be automatic
Left and right activity is got up, and does not stop to do various little tricks on classroom, after lower jump of leaping up when on foot, jump front jumping, a variety of occasions
Under behavior off one's feet;(3) cacesthesia: perception is blunt, all more of the same age to the feeling of things, discrimination, elaborative faculty
Youngster is low.Constantly, not accurate enough to the analysis ability of things, such as: proper motion is normal for mistake often for this infant in daily life
Oneself is injured, concept of space is unclear, and things is out of one's reckoning, for sound, pain etc. without stronger feeling etc.;(4) get excited,
The disturbance of emotion: often mood is apt to change for ADHD infant, will be generated impulsive action by after a dot environmental stimuli, sometimes excited
It dances for joy, love cries and screams, flies into a rage sometimes, and mood constantly and irregularly changes.Disease in school age children is usually quarrelled or is fought with classmate, and thing is encountered
Just make decision when feelings without pondering deeply, follow one's bent, do at will, not only cause itself behavior disorder, return around
Other people cause adverse effect;(5) adapt to obstacle: ADHD infant individual character is prominent, advocates individualistic heroism.Be unwilling and other
Child of the same age plays together, to control other people playing together, can not harmoniously live in collective, class with other classmates
Together, often incompatible with the academic environment of class due to inharmonious with classmate's relationship, therefore, it is difficult to pleasant with classmate
Life, study are together.Such situation makes infant be easy to be isolated by classmate, it is easy to infant heart suffering is caused, when the time is long
Infant becomes unsociable and eccentric, cannot psychologically incorporate in collective livelihood, the management according to teacher, school of being also unwilling in behavior
Regulation is done things, and is considered bad student by others in school;(6) difficulty of learning: although ADHD infant intelligence is learned in normal range (NR)
The main reason for difficult is practised one is the impairment of itself, makes its school grade be lower than normal child of the same age mostly;Secondly infant
It cannot conscientiously be paid attention to the class on most classroom, learning efficiency is decreased obviously, especially the knowledge of natural sciences class, such as calculate, think deeply etc.
Learn relative difficulty.
Human nutrition situation and the relationship of Mental health more and more cause researcher note that also constantly there is scholar's report
There are certain correlations with ADHD for road children's adolescent nutrition situation.American scholar Harding is in 10 ADHD children taking benefits
His woods is given in the comparative study of diet supplement with 10 ADHD children and finds, food replenish improve ADHD child attention and
It is effective in automatic control, and propose may there is same function with using ritalin drug therapy using food supplementary therapy ADHD
Effect.There is provided in the diet of supplement includes: essential fatty acid, phosphatide, vitamin, minerals, nutrient for plants, amino acid etc..
The pathogenesis and unknown etiology as yet of ADHD, larger arguement are whether acquired environment has an impact to it.It focuses mostly in discussion
Gene, society and family factors, Neuropsychological Characteristics etc..With deepening continuously to human spirit's psychological problems research, people
Increasingly find that the nutrition condition of itself plays highly important role.
Treatment children's hyperkinetic syndrome relatively conventional at present is Chinese medicine composition, such as China CN104474341B is disclosed
A kind of pharmaceutical composition for treating children's hyperkinetic syndrome comprising 15-25 parts of the fruit of glossy privet, 10-20 parts of fructus lycii, oyster 10-18
Part, 8-16 parts of mother-of-pearl, 16-24 parts of Os Draconis, 12-26 parts of Fructus Tritici Levis, 6-12 parts of Radix Glycyrrhizae, 10-16 parts of jujube, Radix Codonopsis 8-14
Part, 10-16 parts of the seed of Oriental arborvitae, 10-20 parts of Radix Polygalae, Radix Ophiopogonis 10-20 part, but it is not directed to necessary to human body more comprehensively
Nutriment is not able to satisfy the daily demand of children's hyperkinetic syndrome patient, therefore, develops a facing for children's hyperkinetic syndrome
Bed nutrition product is particularly important.
Summary of the invention
The purpose of the present invention is to overcome the defects in the prior art, provides a kind of clinical nutrition for children's hyperkinetic syndrome
Product helps children to improve hyperactivity shape, the attention of children is improved, in favor of the healthy growth of infant.
To achieve the above object, the present invention adopts the following technical scheme:
The first purpose of the invention is to provide a kind of children's hyperkinetic syndrome tailored version clinical nutrition formulas, which is characterized in that
Including following component and its parts by weight: 10-25 parts of protein, 3-15 parts of fat, 30-60 parts of carbohydrate, 5-25 portions of meals
Eat fiber, 2-5 parts of macroelements, 0.1-0.4 parts of microelements, 0.000001-0.00001 parts of liposoluble vitamins, 0.05-
The new money of 0.3 part of water soluble vitamin, 0.01-3 parts of integration of drinking and medicinal herbs ingredients, 0.5-3 parts of natural plants compounds and 0.01-3 parts
Source food.
In order to advanced optimize above-mentioned clinical nutrition formula, technical measures adopted by the present invention further include:
Further, the protein be selected from PURE WHEY, soybean protein isolate, Isin glue collagen peptide, whole milk powder,
At least one of dried whole-egg, lactoferrin, colostrum, amino acid, protein peptides.
Wherein, the amino acid is selected from L-lysine-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy
At least one of glutamine, taurine, Valine, l-Isoleucine, L-Leu, branched-chain amino acid powder;The albumen
Peptide is selected from soybean oligopeptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin
At least one of peptide.
Further, the protein includes PURE WHEY, soybean protein isolate, Lyophilized Bovine Colostrums, branch ammonia
Base acid powder, taurine.
Further, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO knot
At least one of structure rouge, DHA, EPA, ARA, phosphatide, the more specifically described fat includes safflower seed oil, walnut oil, peanut
Oil, soybean oil, Ah's glycerol, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, perilla herb oil, cupu oil, palm oil, ox
Oil, cream, lard, medium chain triglyceride, lecithin, Purple Perilla Seed Oil etc.;More preferably perilla herb oil microcapsule powder.
Further, the carbohydrate includes fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
In at least two;More preferably maltodextrin.
Further, the dietary fiber includes inulin, konjaku flour, galactooligosaccharide, oligofructose, oligomeric different malt
At least one of sugar, soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber;It is highly preferred that the dietary fiber is resistance
Dextrin and oligofructose.
Further, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, citric acid
At least one of sodium and magnesium gluconate;More preferably: magnesium gluconate, calcium, wherein calcium is with calcium citrate, L-calcium lactate
And/or the form addition of calcium monohydrogen phosphate.
Further, the microelement is selected from ferrous gluconate, potassium iodide, zinc gluconate, sodium selenite, grape
At least one of saccharic acid copper, chromium sulfate, manganese gluconate and sodium molybdate;More preferably: iron, zinc, wherein iron is with gluconic acid
Ferrous and/or zinc gluconate form addition, zinc are added in the form of zinc gluconate.
Further, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, dimension life
Plain K1At least one of;More preferably: vitamin D3。
Further, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, dimension life
At least one of plain C, pantothenic acid, folic acid, niacin, choline, inositol, biotin;More preferably: vitamin B1, vitamin B2, dimension
Raw element B6, vitamin C.
Further, the natural plants compound be selected from L-carnitine, Glucosamine, lutein, phytosterol, kind
At least one of Lycopene, resveratrol, allicin;More preferably L-carnitine.
Further, the integration of drinking and medicinal herbs ingredient is selected from radish seed, fructus lycii, oyster, semen ziziphi spinosae, Radix Glycyrrhizae, arillus longan, Fu
At least one of Siberian cocklebur, jujube, Chinese yam;More preferably: oyster, semen ziziphi spinosae, Radix Glycyrrhizae, arillus longan, Poria cocos, jujube, Chinese yam, specifically
For 0.01-0.5 portions of oysters, 0.01-0.5 parts of semen ziziphi spinosaes, 0.01-0.5 portions of Radix Glycyrrhizaes, 0.01-0.5 portions of arillus longans, 0.01-0.5 parts
Poria cocos, 0.01-0.5 portion jujube, 0.01-0.5 portions of Chinese yams.
Further, it is few to be selected from first milk basic protein, hydrolysis yolk powder, γ-aminobutyric acid, shell for the new resource food
Sugar, eucommia Bark male flower, bamboo-leaves flavones, casein phosphopeptide, fish oil, avenabeta glucosan, Oligomeric manna sugar, Rosa roxburghii Tratt, yeast β-Portugal
At least one of glycan, newborn mineral salt, pueraria root powder, Rosa roxburghii Tratt, xylo-oligosaccharide;It is highly preferred that the new resource food is γ-ammonia
Base butyric acid, fish oil, wherein the fish oil uses fish oil microcapsule powder.
Further, above-mentioned nutrient formulation may also include nucleotide, be specially 5 ' monophosphate cytidines.
Further, above-mentioned nutrient formulation may also include diet essence, the diet essence be selected from cereal, beans, potato,
At least one of greengrocery, Homonemeae, nut-seed class, fish and shrimp, poultry meat, fruits;The cereal is selected from rice
At least one of powder, millet flour, black rice flour, coixlacrymajobi powder, corn flour, wheat germ powder, oatmeal, buckwheat;The beans
At least one selected from peameal, mung bean flour, black bean powder, red bean powder, soy meal;The potato is mainly made of common yam rhizome powder;Institute
State at least one of Vegetable powder in carrot meal, white radish powder, pumpkin powder, spinach powder, tomato meal, broccoli powder, balsam pear powder
Kind;The Homonemeae is selected from least one of mushroom powder, Kelp Powder and tremella powder;The nut-seed class is selected from pumpkin seed powder
At least one of with lotus nut starch;The fish and shrimp are selected from least one of salmon powder and cod meal;The poultry meat
Selected from least one of chicken meal, powdered beef, pork liver powder and pig kidney powder;The fruits are selected from red date powder, longan powder, apple
At least one of powder, cherry powder, citrus powder, pyrus nivalis powder.
Further, above-mentioned nutrient formulation may also include cycle of sixty years and heart, and additive amount is 0.5~2 part, has and mends
Iron, zinc supplementation nourish heart, improve cranial nerve function, have significant curative effect to children's hyperkinetic syndrome is alleviated.
Further, the children's hyperkinetic syndrome tailored version clinical nutrition formula includes: maltodextrin, PURE WHEY, resists
Property dextrin, oligofructose, soybean protein isolate, perilla herb oil microcapsule powder, magnesium gluconate, fish oil microcapsule powder, branched-chain amino acid powder,
Oyster, semen ziziphi spinosae, Radix Glycyrrhizae, arillus longan, Poria cocos, jujube, Chinese yam, Lyophilized Bovine Colostrums, γ-aminobutyric acid, L-carnitine, calcium,
Iron, zinc, vitamin D3, vitamin B1, vitamin B2, vitamin B6, vitamin C, taurine.
A second object of the present invention is to provide a kind of preparation sides of above-mentioned children's hyperkinetic syndrome tailored version clinical nutrition formula
Method method comprising following steps:
Step 1) prepares fat powder, liposoluble vitamin powder and water soluble vitamin powder using micro-capsule embedding techniques
End;
Step 2) mentioned using crushing, alcohol extracting, water, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders;
Step 3) is smart by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, microelement, diet
China, natural plants compound and new resource food are prepared into the powder that partial size is 150~250 μm respectively, if necessary
Above-mentioned raw materials can be carried out in advance baking processing;
Step 4) is by step 1)~3) powder of preparation sterilize after mixing it is spare;
The mixed powder of step 4) is prepared into nutrient powder, nutrition emulsion, capsule according to conventional technical means by step 5)
At least one of agent, tablet, pill or oral solution;
Wherein, step 1) -3) sequence can mutually replace.
Finally, the present invention relates to a kind of products prepared by above-mentioned children's hyperkinetic syndrome tailored version clinical nutrition formula, including
Nutrient powder, nutrition emulsion, capsule, tablet, pill, oral solution etc..
In the above preparation method, wherein the raw material of the integration of drinking and medicinal herbs ingredient crushed, alcohol extracting concentration, water concentrate
Contracting, and concentrate is subjected to spray drying, integration of drinking and medicinal herbs component powders are made;Wherein, the vitamin and fat are respectively by micro-
Encapsulated processing is prepared into vitamin powder and fat powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows: using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, and 7~8 times of 30~40% second that weight is raw material weight are added
Alcohol is impregnated, is extracted 3 times, is merged alcohol extract and is concentrated into no alcohol taste;After the raw medicine dregs of a decoction fling to ethyl alcohol, it is original that weight, which is added,
3~4 times of water of material weight is impregnated, and carries out 15~20min of decoction to soak, filtering removal raw material leaves and takes decoction
Liquid;Alcohol extract and decoction liquor after merging concentration, and it is spray-dried, it is same finally to prepare medicine food with 60~80 meshes point
Derived components powder.
Preferably, specific step is as follows for the microencapsulation processing of the vitamin: 1) using liposoluble vitamin as core
Material selects sodium carboxymethylcellulose, gelatin, carragheen, xanthan gum, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One of powder, emulsifier, stabilizer are a variety of as wall material, and high-pressure homogeneous emulsification is spraying instantaneous dry, with 60~80 meshes
Divide and prepares liposoluble vitamin powder;2) using water soluble vitamin as core material, sodium carboxymethylcellulose, gelatin, OK a karaoke club are selected
Glue, xanthan gum, Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, chrysanthemum
One of powder, PURE WHEY, oligoisomaltose, soybean fiber, lactose, candy sugar powder, emulsifier, stabilizer or a variety of works
For wall material, it is uniformly mixed, it is spraying instantaneous dry, water soluble vitamin powder is prepared with 60~80 meshes point.
Preferably, the specific implementation step of the micro-capsule embedding techniques of the fat is as follows: by fat, emulsifier, wall material with
Water mixed dissolution prepares emulsion;After above-mentioned emulsion is stirred, emulsifying homogeneous processing is carried out, is then done by spraying
Dry, screening prepares fat powder, and fat powder is compared with conventional grease, and dispersibility, water solubility, emulsibility, inoxidizability are all
It improves a lot;Wherein, the emulsifier be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
Sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin, monoglyceride, one in Tween 80
Kind is a variety of;The wall material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthan gum, Arabic gum, maltodextrin, rouge egg
White, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean
One of fiber, lactose, candy sugar powder, emulsifier, stabilizer are a variety of.
The present invention also provides a kind of preparation methods of above-mentioned a variety of disease tailored version clinical nutrition formulas of children, are wet process work
Skill includes the following steps:
Step 1) prepare the protein containing predetermined weight number, fat, carbohydrate, dietary fiber, macroelement,
Microelement, vitamin, integration of drinking and medicinal herbs ingredient, natural plants compound and new resource food raw material, in predetermined amount
It in water, according to the physical behavior of raw material, is successively added according to sequencing, is stirred while addition, raw material is made
Mixed emulsion;
The mixed emulsion temperature that step 1) obtains is maintained at 40-50 DEG C by step 2), and adjustment homogenization pressure protects it always
It holds between 10-18Mpa, emulsifying homogeneous is carried out to mixed emulsion, is then placed emulsion in evaporator, with preset technology
Parameter is concentrated, and is sterilized at 85-88 DEG C, and concentrate is obtained;
The concentrate that step 2) obtains is spray-dried by step 3), is crossed 60~80 meshes, is prepared into powder;Using upper
It states powder and is prepared at least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution.
Using the integration of drinking and medicinal herbs ingredient for including oyster, semen ziziphi spinosae, Radix Glycyrrhizae, arillus longan, Poria cocos, jujube, Chinese yam in the present invention;
Wherein, it is rich in vitamin and minerals in oyster, is conducive to the effects of adjusting nerve, setting the mind at rest;Semen ziziphi spinosae has calming heart
Sedative action;Radix Glycyrrhizae play the role of nourishing heart allay excitement, easing up the urgency with moist and sweet drugs;Arillus longan has tonifying heart and spleen, nourishing blood and tranquilization effect;Poria cocos has
The effect of tranquilizing and allaying excitement;Jujube has the function of tonifying middle-Jiao and Qi, health care stomach, calms the nerves and enrich blood;Chinese yam has strengthening spleen and nourishing stomach, beneficial lung
Effect.Have the function of alleviating each symptom of children's hyperkinetic syndrome patient after mentioned component compatibility synergy and improves its concentrated force.
Compared with prior art, the invention has the following advantages:
Children's hyperkinetic syndrome tailored version clinical nutrition formula supplement addition zinc, magnesium, calcium of the present invention, zinc have a variety of lifes
Object function such as participates in the composition of many enzymes, and required for the activity of enzyme;In protein synthesis and amino acid metabolism mistake
Cheng Zhong and indispensable ingredient;Zinc has protective effect to nerve cell film integrality, the growth and brain function to normal brain activity
Maintenance play an important role, become together with calcium, potassium, sodium central nervous system neurons excitatoty one it is key
Instrumentality.Magnesium has different physiological roles, and a variety of enzyme systems can be activated to participate in the metabolism of body sugar, protein, fat.To mind
Have through movable control, the transmitting of neural muscle excitability, the contraction of muscle, heart activation and antiotasis etc. important
Effect;Discovered in recent years magnesia mixture is a kind of important neuroprotective agent and EAA antagonists, can remain neural thin
The oxidative phosphorylation reaction of born of the same parents, the synthesis of protein and phosphatide, increase brain cell energy supply, reduce free radical and generate;
Meanwhile reaction of the histocyte to insulin can be promoted, accelerate glucose clearance, the acidic metabolic for reducing cerebral apoplexy position produces
Object, reduces the range of cerebral arterial thrombosis, to mitigate the damage of brain tissue.Calcium is the activator of neuron metabolism, works as mind
When reaching the cynapse of nerve endings through impulsion, synaptic membrane generates action potential, membrane depolarization, calcium ion due to ion-transfer
Stream enters cell in a manner of equilibrium potential difference, promotes neural vesicle to contact with synaptic membrane and passs to synaptic cleft release nerve
Matter.The inside and outside transfer of calcium ion cell membrane in this course is necessary, while also relying on the concentration of calcium transfer to response intensity
It is adjusted, reacts strong when calcium concentration is high, it is on the contrary then weak.Due to calcium nerve modulation effect to excitatory transmitter (second phthalein choline,
Norepinephrine) and inhibitory transmitter (the light tryptamines of dopamine, 5-, γ-aminobutyric acid) effect having the same, therefore work as machine
When body calcium deficiency, neurotransmitter regulator is affected, and the excitement of nervous system and inhibition function get muddled.Match simultaneously in the nutrition
Fang Zhong, also addition vitamin C, to improve iron, calcium utilization participates in the effects of synthesizing neurotransmitter.
Children's hyperkinetic syndrome tailored version clinical nutrition formula of the present invention also adds branched-chain amino acid, in protein in body
Also important adjustment effect is played in matter, carbohydrate and lipid-metabolism.Branched-chain amino acid decline shows body catabolism
Increase, illustrates that body is in stress situation, energy consumption increases;This decline can influence protein synthesis simultaneously, cause immune function decline
And compromised brain function.And add γ-aminobutyric acid, γ-aminobutyric acid belongs to inhibitory aminoacid (IAA), IAA metabolism and/or
Change to brain transport process, results in the change of nervous function, thus there is the increased symptom of excitability, it is such as more
Dynamic, absent minded and impulsive action etc..
The present invention also adds fish oil, and omega-3 fatty acid is the essential component for constituting brain cell membrane, and maintenance brain is good for
The important person who has rendered outstanding service of health, it can make chemical message, and successfully efficient communication is made in transmission between brain cell, and fish oil can not only increase
Strong learning ability, memory and concentration, can also alleviate pressure.
The present invention is by selecting reasonable basal nutrient element, using the proportion of general equilibrium, while adding small with adjusting
Integration of drinking and medicinal herbs ingredient, the natural plants chemical combination of youngster hyperactivity patient memory, concentration and study idea, stable patient mood etc.
The specific nutrients such as object, new resource food, and adjust its proportion and carry out compatibility synergy with basal nutrient element, it is more that children are supplemented comprehensively
The dynamic daily required necessary nutritional ingredient of disease patient, and the nutrient formulation is easier to be absorbed by children's hyperkinetic syndrome people digest, fills
The effect of its each component is waved in distribution effectively guarantees nutrient necessary to patient's growth and development, and alleviates and treat related more
The symptom of dynamic disease makes patient be easier to incorporate the daily life of normal population to improve the psychological problems of patient.
Specific embodiment
The present invention provides a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula comprising following component and its parts by weight
Number: 10-25 parts of protein, 3-15 parts of fat, 30-60 parts of carbohydrate, 5-25 parts of dietary fibers, 2-5 parts of macroelements,
0.1-0.4 parts of microelements, 0.000001-0.00001 parts of liposoluble vitamins, 0.05-0.3 parts of water soluble vitamins,
0.01-3 parts of integration of drinking and medicinal herbs ingredients, 0.5-3 parts of natural plants compounds and 0.01-3 parts of new resource foods.
With reference to embodiment, the specific embodiment of the present invention is further described.Following embodiment is only used for more
Add and clearly demonstrate technical solution of the present invention, and not intended to limit the protection scope of the present invention.
Embodiment 1
Children's hyperkinetic syndrome tailored version clinical nutrition formula of the present invention includes maltodextrin 40g, PURE WHEY
10g, resistant dextrin 10g, oligofructose 10g, soybean protein isolate 8g, perilla herb oil microcapsule powder 5g, magnesium gluconate 3.5g, fish oil
Microcapsule powder 2g, branched-chain amino acid powder 2g, oyster 0.5g, semen ziziphi spinosae 0.2g, Radix Glycyrrhizae 0.5g, arillus longan 0.2g, Poria cocos 0.5g, jujube
0.2g, Chinese yam 0.2g, Lyophilized Bovine Colostrums 0.5g, γ-aminobutyric acid 0.2g, L-carnitine 1g, calcium 0.37g, iron 0.17g, zinc
0.13g, vitamin D30.0000013g, vitamin B10.002g, vitamin B20.002g, vitamin B60.002g, dimension life
Plain C0.198g, taurine 0.12g.
Embodiment 2
Children's hyperkinetic syndrome tailored version clinical nutrition formula of the present invention includes maltodextrin 40g, PURE WHEY
10g, resistant dextrin 10g, oligofructose 10g, soybean protein isolate 8g, perilla herb oil microcapsule powder 5g, magnesium gluconate 3.5g, fish oil
Microcapsule powder 0.02g, branched-chain amino acid powder 2g, oyster 0.5g, semen ziziphi spinosae 0.2g, Radix Glycyrrhizae 0.5g, arillus longan 0.2g, Poria cocos 0.5g,
Jujube 0.2g, Chinese yam 0.2g, Lyophilized Bovine Colostrums 0.5g, γ-aminobutyric acid 0.01g, L-carnitine 1g, calcium 0.37g, iron
0.17g, zinc 0.13g, vitamin D30.0000013g, vitamin B10.002g, vitamin B20.002g, vitamin B6
0.002g, vitamin C 0.198g, taurine 0.12g.
Embodiment 3
Children's hyperkinetic syndrome tailored version clinical nutrition formula of the present invention includes maltodextrin 40g, PURE WHEY
10g, resistant dextrin 10g, oligofructose 10g, soybean protein isolate 8g, perilla herb oil microcapsule powder 5g, magnesium gluconate 3.5g, fish oil
Microcapsule powder 0.02g, branched-chain amino acid powder 2g, oyster 0.01g, semen ziziphi spinosae 0.01g, Radix Glycyrrhizae 0.01g, arillus longan 0.01g, Poria cocos
0.01g, jujube 0.01g, Chinese yam 0.01g, Lyophilized Bovine Colostrums 0.5g, γ-aminobutyric acid 0.01g, L-carnitine 1g, calcium
0.37g, iron 0.17g, zinc 0.13g, vitamin D30.0000013g, vitamin B10.002g, vitamin B20.002g, dimension life
Plain B60.002g, vitamin C 0.198g, taurine 0.12g.
Embodiment 4
It is a kind of as embodiment 1~children's hyperkinetic syndrome described in embodiment 3 tailored version clinical nutrition formula preparation method such as
Under:
1) powdered oil (powder fat) is prepared:
A) it prepares wall material aqueous solution: taking 8 grams of maltodextrin, 11 grams of whole-fat milk powder, dietary fiber 2 grams of (resistant dextrin), chrysanthemums
0.5 gram of powder, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, 0.2 gram of Arabic gum, 0.5 gram of lactose,
2 grams of candy sugar powder, 50 milliliters of water stir evenly (have ready conditions and heat while stirring to 60 DEG C, keep 30 minutes after be cooled to room temperature).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (perilla herb oil in 4.69 milliliters of greases monoglyceride
4.69 milliliter).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1 gram (total solid concentration be 0.2%) into after mixed solution, is settled to water
200 milliliters (total solid concentration be 25%), high speed dispersion 2 minutes under 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous 3 times (every time 5 minutes), homogeneous emulsion is made.
G) emulsion obtained is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C.Collect powder
Grease (powder fat), i.e. perilla herb oil microcapsule powder;
The identical mode with step 1) is taken to prepare fish oil microcapsule powder.
2) integration of drinking and medicinal herbs component powders are prepared: being crushed, will be crushed using raw material of the pulverizer to predetermined weight number
Raw material be placed in container, crushed using raw material of the pulverizer to predetermined weight number, the raw material of crushing be placed in container
In, 4 times of 75% ethyl alcohol that weight is raw material weight is added, impregnated, extracted 2 times, merges alcohol extract and is concentrated into no alcohol
Taste;After the raw medicine dregs of a decoction fling to ethyl alcohol, 6 times of the water that weight is raw material weight is added and is impregnated, soak is decocted
45min, filtering removal raw material, leaves and takes decoction liquor;Alcohol extract and decoction liquor after merging concentration, and it is spray-dried,
Finally integration of drinking and medicinal herbs component powders are prepared with 60 meshes point;
3) it prepares vitamin powder: using the liposoluble vitamin of predetermined weight number as core material, selecting oligomeric different malt
Sugar is used as wall material, carries out 2 emulsifying homogeneous processing under high pressure, and the emulsifying homogeneous time is 15min, is then instantaneously done by spraying
It is dry, liposoluble vitamin powder is prepared with 80 meshes point;Using the water soluble vitamin of predetermined weight number as core material, wheat is selected
Bud dextrin, oligoisomaltose are uniformly mixed as wall material, spraying instantaneous dry, prepare water soluble vitamin with 80 meshes point
Powder;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, microelement, diet essence,
Natural plants compound and new resource food are prepared into the powder that partial size is 200 μm respectively;(step 1) -4) sequence can phase
Mutually replacement)
5) by step 1) -4) preparation powder sterilized after mixing in the similar devices such as mixing machine it is spare;
6) according to conventional technical means by the powder in step 5) be prepared into nutrient powder, nutrition emulsion, capsule, tablet,
At least one of pill or oral solution.
In step 6), optionally increase suitable food thickening agent, food additives and related dosage form auxiliary material.
The food thickening agent is guar gum, in xanthan gum, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
At least one, the food additives be at least one of Aspartame, edible essence fragrance, brown sugar;More preferable OK a karaoke club
Glue, Arabic gum, guar gum, Aspartame, edible essence fragrance.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder explosion.
It can be prepared into the classifications such as powdery, graininess, capsule shape, tablet shape, beverage according to the formula.
Embodiment 5
The present embodiment verifies influence of the nutrient formulation of the present invention to children's hyperkinetic syndrome.The present embodiment uses embodiment
The nutrient powder and following comparative examples of 1 formula preparation:
Comparative example 1: the Chinese medicine composition of commercially available treatment children's hyperkinetic syndrome, by specification are taken;
Comparative example 2: the Western medicine ritalin of commercially available treatment children's hyperkinetic syndrome, by specification are taken;
Comparative example 3: not adding fish oil microcapsule powder and γ-aminobutyric acid, the battalion that remaining component is prepared by the formula of embodiment 1
Support powder;
Comparative example 4: not adding integration of drinking and medicinal herbs ingredient, the nutrient powder that remaining component is prepared by the formula of embodiment 1;
Comparative example 5: not adding macroelement, microelement and vitamin, remaining component is prepared by the formula of embodiment 1
Nutrient powder;
Comparative example 6: addition cycle of sixty years and each 0.8g of Pigs Hearts, cycle of sixty years and Pigs Hearts are all made of freeze-dried powder technology and are prepared into powder,
The nutrient powder that remaining component is prepared by the formula of embodiment 1.
7 groups of experimental group of setting, children's hyperkinetic syndrome patient 20 of corresponding nutrient powder are voluntarily taken in every group of selection, and nutrient powder is every
Day takes three times, brews 150mg every time.Each 10 parts of men and women of the patient that above-mentioned each experimental group uses, the age at 7~12 years old,
The course of disease is 6 months~4 years, continuously takes related preparations 8 weeks, and carries out curative effect judgement with following standards:
(1) fully recover: cardinal symptom disappears, and mostly dynamic index score reduces > 80%, and school grade significantly improves, and is discontinued 0.5 year
Efficacy consolidation;
(2) effective: cardinal symptom is obviously improved, and mostly dynamic index score reduces > 50%, and school grade has to be mentioned in various degree
It is high;
(3) effectively: cardinal symptom improves, and mostly dynamic index score reduces > 30%, and school grade improves, but unstable;
(4) invalid: above-mentioned symptom and index without improvement or deteriorate.
The treatment results of above-mentioned experimental group are as shown in the table:
Group | Recovery from illness | It is effective | Effectively | In vain | Total effective rate | Total effective rate |
Example 1 group | 3 | 7 | 8 | 2 | 50% | 90% |
1 group of comparative example | 2 | 6 | 5 | 7 | 40% | 65% |
2 groups of comparative example | 1 | 8 | 3 | 8 | 45% | 60% |
3 groups of comparative example | 2 | 6 | 7 | 5 | 40% | 75% |
4 groups of comparative example | 1 | 5 | 7 | 7 | 30% | 65% |
5 groups of comparative example | 1 | 4 | 12 | 3 | 25% | 85% |
6 groups of comparative example | 3 | 8 | 6 | 3 | 55% | 85% |
As seen from the above table, compared with comparative example 1~2 (existing preparation), 1 nutrient formulation of embodiment and addition are pressed in the present invention
Active cycle of sixty years and the nutrient powder of comparative example 6 nutrient formulation of Pigs Hearts preparation are that children's hyperkinetic syndrome patient has more excellent treatment
Effect, and for comparative example 3~5, though having the effect of certain, its effect is slightly weaker than nutrient formulation of the present invention,
This shows that each component combination and compatibility uses in the nutrient formulation of the invention used, produces synergistic beneficial effect.
Through the foregoing embodiment it is found that children's hyperkinetic syndrome tailored version clinical nutrition formula of the present invention is closed by selecting
The basal nutrient element of reason using the proportion of general equilibrium, while adding to have and adjusting children's hyperkinetic syndrome patient memory, concentration
With the specific nutrients such as study idea, the integration of drinking and medicinal herbs ingredient for stablizing patient mood etc., natural plants compound, new resource food,
And adjust its proportion and carry out compatibility synergy with basal nutrient element, the daily required necessary nutrition of children's hyperkinetic syndrome patient is supplemented comprehensively
Ingredient, and the nutrient formulation is easier the effect of being absorbed by children's hyperkinetic syndrome people digest, giving full play to its each component, effectively
Guarantee nutrient necessary to patient's growth and development, and alleviate and treat the symptom of related hyperactivity, to improve the psychology of patient
Problem makes patient be easier to incorporate the daily life of normal population.
Specific embodiments of the present invention are described in detail above, but it is only used as example, the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, the equivalent modifications and replace that any couple of present invention carries out
In generation, is also all among scope of the invention.Therefore, without departing from the spirit and scope of the invention made by equal transformation and repair
Change, all should be contained within the scope of the invention.
Claims (10)
1. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula, which is characterized in that including following component and its parts by weight:
10-25 parts of protein, 3-15 parts of fat, 30-60 parts of carbohydrate, 5-25 parts of dietary fibers, 2-5 parts of macroelements, 0.1-
0.4 part of microelement, 0.000001-0.00001 parts of liposoluble vitamins, 0.05-0.3 parts of water soluble vitamins, 0.01-3 parts
Integration of drinking and medicinal herbs ingredient, 0.5-3 parts of natural plants compounds and 0.01-3 parts of new resource foods;
Wherein, the protein includes PURE WHEY, soybean protein isolate, bovine colostrum, taurine, branched-chain amino acid powder;
The new resource food includes γ-aminobutyric acid;Wherein, the integration of drinking and medicinal herbs at selected from radish seed, fructus lycii, oyster, semen ziziphi spinosae,
At least one of Radix Glycyrrhizae, arillus longan, Poria cocos, jujube, Chinese yam.
2. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that the fat
Including safflower seed oil, walnut oil, peanut oil, soybean oil, Ah's glycerol, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil,
At least one of perilla herb oil, cupu oil, palm oil, butter, cream, lard, medium chain triglyceride, lecithin, Purple Perilla Seed Oil.
3. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that the medicine food
With derived components include: 0.01-0.5 portions of oysters, 0.01-0.5 parts of semen ziziphi spinosaes, 0.01-0.5 portions of Radix Glycyrrhizaes, 0.01-0.5 portions of arillus longans,
0.01-0.5 parts of Poria cocos, 0.01-0.5 portions of jujubes, 0.01-0.5 portions of Chinese yams.
4. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that described natural
Plant compound is in L-carnitine, Glucosamine, lutein, phytosterol, lycopene, resveratrol, allicin
At least one.
5. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that the constant
Element includes calcium and magnesium, and the microelement includes zinc, and the water soluble vitamin includes vitamin C.
6. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that the diet
Fiber includes inulin, konjaku flour, galactooligosaccharide, oligofructose, oligoisomaltose, soybean polyoses, cyclodextrin, resistance paste
At least one of essence, soybean fiber.
7. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that the nutrition
Formula may also include cycle of sixty years and heart, and additive amount is 0.5~2 part.
8. a kind of children's hyperkinetic syndrome tailored version clinical nutrition formula according to claim 1, which is characterized in that the children
Hyperactivity tailored version clinical nutrition formula includes: maltodextrin, PURE WHEY, resistant dextrin, oligofructose, soybean separation protein
White, perilla herb oil microcapsule powder, magnesium gluconate, fish oil microcapsule powder, branched-chain amino acid powder, oyster, semen ziziphi spinosae, Radix Glycyrrhizae, arillus longan, Fu
Siberian cocklebur, jujube, Chinese yam, Lyophilized Bovine Colostrums, γ-aminobutyric acid, L-carnitine, calcium, iron, zinc, vitamin D3, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin C, taurine.
9. a kind of preparation method of such as children's hyperkinetic syndrome tailored version clinical nutrition formula according to any one of claims 1 to 8,
It is characterized by comprising the following steps:
The preparation of micro-capsule embedding techniques is respectively adopted simultaneously in the fat, liposoluble vitamin, water soluble vitamin of step (1) predetermined weight
It crosses 60~80 meshes and powder is made;
The integration of drinking and medicinal herbs ingredient of step (2) predetermined weight is mentioned by crushing, alcohol extracting, water, is spray-dried and cross 60-80 mesh and is made
Powder;
Remaining component of step (3) predetermined weight is prepared into the powder that partial size is 150~250 μm respectively;
Step (4) sterilizes powder prepared by step (1)~(3) spare after mixing;
Direct-edible pharmaceutical formulation is made in step (4) mixed powder by step (5);
Wherein, step (1)~(3) sequence can be replaced mutually;The pharmaceutical formulation include nutrient powder, nutrition emulsion, capsule,
Tablet, pill, oral solution.
10. the preparation method of tailored version clinical nutrition formula is energized when production described according to claim 1~any one of 8,
It is characterized in that, includes the following steps:
Step 1) prepares the protein containing predetermined weight number, fat, carbohydrate, dietary fiber, macroelement, micro
Element, vitamin, integration of drinking and medicinal herbs ingredient, natural plants compound and new resource food raw material powder, in predetermined amount
It in water, according to the physical behavior of raw material, is successively added according to sequencing, is stirred while addition, raw material is made
Mixed emulsion;
The mixed emulsion that step 2) obtains step 1) carries out emulsifying homogeneous, concentrating sterilizing, obtains concentrate;
The concentrate that step 2) obtains is spray-dried by step 3), and sieving is prepared into powder, and above-mentioned powder is prepared into
At least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910267975.3A CN109965273A (en) | 2019-04-03 | 2019-04-03 | A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910267975.3A CN109965273A (en) | 2019-04-03 | 2019-04-03 | A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109965273A true CN109965273A (en) | 2019-07-05 |
Family
ID=67082897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910267975.3A Withdrawn CN109965273A (en) | 2019-04-03 | 2019-04-03 | A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109965273A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110237062A (en) * | 2019-07-10 | 2019-09-17 | 吉林农业大学 | It is a kind of using gucosamine as the preparation that can enhance attention of regulator |
CN115317507A (en) * | 2022-09-19 | 2022-11-11 | 中国科学院海洋研究所 | Application of low molecular weight fucoidan in preparation of anti-hyperactivity drugs |
WO2024057139A1 (en) * | 2022-09-14 | 2024-03-21 | Abiogen Pharma Spa | Composition comprising l-leucine and fish oil |
-
2019
- 2019-04-03 CN CN201910267975.3A patent/CN109965273A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110237062A (en) * | 2019-07-10 | 2019-09-17 | 吉林农业大学 | It is a kind of using gucosamine as the preparation that can enhance attention of regulator |
WO2024057139A1 (en) * | 2022-09-14 | 2024-03-21 | Abiogen Pharma Spa | Composition comprising l-leucine and fish oil |
CN115317507A (en) * | 2022-09-19 | 2022-11-11 | 中国科学院海洋研究所 | Application of low molecular weight fucoidan in preparation of anti-hyperactivity drugs |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Balch | Prescription for nutritional healing | |
CN104780781B (en) | The method adjusting the individual Corticosterone Level of psychological stress | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN104822279A (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
CN109965026A (en) | A kind of formula milk and preparation method thereof promoting child growth | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN109965273A (en) | A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
CN105072928A (en) | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof | |
CN101842094A (en) | Anti-fatigue agent comprising amino acid composition | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN108703364A (en) | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
Mudambi | Fundamentals of foods and nutrition | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN105432792A (en) | Basic nutrition milk powder for preschool children, nutrition milk powder suit and preparation methods | |
CN109965271A (en) | A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof | |
CN110214942A (en) | A kind of hyperthyroidism tailored version Nutrition formula and preparation method thereof | |
Singh et al. | Food nutrition, science and technology | |
JP2002255846A (en) | Oral composition | |
JPH09124473A (en) | Enhancer for physical fitness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190705 |
|
WW01 | Invention patent application withdrawn after publication |